Xeris Biopharma Holdings Inc (XERS)

May 02, 2026

Insider Sell Alert: Beth Hecht Sells 16,667 Shares of Xeris Biop - GuruFocus

May 02, 2026

May 01, 2026

Insider Sell Alert: Beth Hecht Sells 16,667 Shares of Xeris Biopharma Holdings Inc (XERS) - GuruFocus

May 01, 2026

May 01, 2026

Beth Hecht Sells 16,667 Shares of Xeris Biopharma (NASDAQ:XERS) Stock - MarketBeat

May 01, 2026

May 01, 2026

Xeris Biopharma’s chief legal officer sells $103,805 in stock - Investing.com

May 01, 2026

May 01, 2026

Xeris Biopharma (XERS) officer sells 16,667 shares under 10b5-1 plan - Stock Titan

May 01, 2026

Apr 30, 2026

Xeris Biopharma (XERS) to Release Earnings on Thursday - MarketBeat

Apr 30, 2026

Apr 28, 2026

Xeris Biopharma Reports Third Quarter 2024 Financial Results - Quantisnow

Apr 28, 2026

Apr 27, 2026

Xeris Biopharma Holdings, Inc. (XERS) Hit a 52 Week High, Can the Run Continue? - MSN

Apr 27, 2026

Apr 26, 2026

Xeris Biopharma expects full-year 2025 revenue above estimates - MSN

Apr 26, 2026

Apr 24, 2026

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Apr 24, 2026

Apr 23, 2026

Xeris Biopharma to Report First Quarter 2026 Financial Results on May 7, 2026 - BioSpace

Apr 23, 2026

Apr 23, 2026

Xeris Biopharma Holdings, Inc. ($XERS) CEO 2025 Pay Revealed - Quiver Quantitative

Apr 23, 2026

Apr 23, 2026

[ARS] Xeris Biopharma Holdings, Inc. SEC Filing - Stock Titan

Apr 23, 2026

Apr 23, 2026

Xeris Biopharma (NASDAQ: XERS) details 2026 votes on pay, board, auditor - Stock Titan

Apr 23, 2026

Apr 23, 2026

Xeris (XERS) Year-Ahead Outlook | Q4 2025: EPS Exceeds ExpectationsDark Pool - Cổng thông tin điện tử Tỉnh Sơn La

Apr 23, 2026

Apr 21, 2026

Xeris Biopharma director Jeffrey Sherman to retire after 2026 annual meeting - Investing.com India

Apr 21, 2026

Apr 21, 2026

Xeris Biopharma director Jeffrey Sherman to retire after 2026 annual meeting By Investing.com - Investing.com South Africa

Apr 21, 2026

Apr 21, 2026

Xeris Biopharma Announces Board Transition as Director Retires - TipRanks

Apr 21, 2026

Apr 21, 2026

Xeris Biopharma's Jeffrey Sherman to Retire from Board - TradingView

Apr 21, 2026

Apr 21, 2026

Director Jeffrey Sherman to retire from Xeris Biopharma (XERS) board in 2026 - Stock Titan

Apr 21, 2026

Apr 20, 2026

Xeris Biopharma stock (US98422E1038): Is its rare disease focus strong enough to drive sustained gro - AD HOC NEWS

Apr 20, 2026

Apr 18, 2026

Xeris Biopharma stock (US98422E1038): Is its rare disease focus strong enough to unlock new upside? - AD HOC NEWS

Apr 18, 2026

Apr 17, 2026

Xeris Biopharma Holdings, Inc. $XERS Shares Sold by Tudor Investment Corp ET AL - MarketBeat

Apr 17, 2026

Apr 17, 2026

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: Uncovering an 82% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

Apr 17, 2026

Apr 15, 2026

Xeris (XERS) Stock: Investment Decision (+2.14%) 2026-04-15Community Watchlist - UBND thành phố Hải Phòng

Apr 15, 2026

Apr 14, 2026

Record Profitability, 2026 Growth Outlook and Recorlev Patent Suit Might Change The Case For Investing In Xeris Biopharma Holdings (XERS) - Sahm

Apr 14, 2026

Apr 13, 2026

Barclays Initiates Coverage on Xeris Biopharma Holdings (XERS) w - GuruFocus

Apr 13, 2026

Apr 13, 2026

XERS.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Apr 13, 2026

Apr 13, 2026

Does Record Q4 Results, Robust 2026 Guidance and Recorlev Patent Suit Change The Bull Case For Xeris (XERS)? - Yahoo Finance

Apr 13, 2026

Apr 13, 2026

Is Xeris (XERS) Stock Overvalued Now | Price at $5.87, Up 0.26%Expert Market Insights - Cổng thông tin điện tử tỉnh Lào Cai

Apr 13, 2026

Apr 10, 2026

XERS.O Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 10, 2026

Apr 09, 2026

Earnings Recap: Why is Xeris Biopharma Holdings Inc stock going upWeekly Stock Summary & Verified Short-Term Trading Plans - baoquankhu1.vn

Apr 09, 2026

Apr 09, 2026

What limits growth of Xeris (XERS) Stock | XERS Q4 Earnings: Beats Estimates by $0.02Revenue Growth Rate - Xã Thanh Hà

Apr 09, 2026

Apr 08, 2026

Q1 2025 Xeris Biopharma Holdings Inc Earnings Call Transcript - GuruFocus

Apr 08, 2026

Apr 08, 2026

XERS Should I Buy - Intellectia AI

Apr 08, 2026

Apr 08, 2026

XERS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 08, 2026

Apr 08, 2026

Apella Capital LLC Acquires 235,897 Shares of Xeris Biopharma Holdings, Inc. $XERS - MarketBeat

Apr 08, 2026

Apr 08, 2026

A Look At Xeris Biopharma Holdings (XERS) Valuation After Its Q4 2025 Earnings Beat - Sahm

Apr 08, 2026

Apr 06, 2026

Should I Buy Xeris (XERS) Stock Today | Price at $6.05, Up 0.17%Value Ideas - Xã Thanh Hà

Apr 06, 2026

Apr 06, 2026

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)April 3, 2026 - BioSpace

Apr 06, 2026

Apr 05, 2026

Oppenheimer Maintains Xeris Biopharma Holdings (XERS) Outperform Recommendation - MSN

Apr 05, 2026

Apr 04, 2026

XERS Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 04, 2026

Apr 03, 2026

Xeris Biopharma (NASDAQ:XERS) Insider Sells $99,835.33 in Stock - MarketBeat

Apr 03, 2026

Apr 03, 2026

Beth Hecht Sells 16,667 Shares of Xeris Biopharma Holdings Inc (XERS) - GuruFocus

Apr 03, 2026

Apr 03, 2026

Xeris Biopharma Approves Inducement Grants for 50,000 Shares to Two New Employees - geneonline.com

Apr 03, 2026